glp 1 and fasting GLP-1 meds don't work the same for everyone — here's what new research is revealing. GLP-1 receptor agonists are one of the most talked-about medication classes for obesity type 2 diabetes — The biomarkers to watch when

This is all very disappointing

I feel 10years younger Great experience with the glutathione kit

Head to head comparisons show semaglutide produces greater mean HbA1c reduction and weight loss than dulaglutide at clinically relevant doses

Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,049 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits

The 48 insurer pledges coordinated through AHIP after the June 2025 meeting with HHS Secretary Kennedy and CMS Administrator Oz took effect on January 1, 2026 ( [15] )